In January, the outgoing chief of ZeptoMetrix, Gregory R. Chiklis, sued the company in the New York State Supreme Court and accused the company of financial irregularities, including paying the “phantom employees” annual wages of $ 500,000. Mr Chiklis also said that Collins “unilaterally” took most decisions.
The case was settled later, and Chiklis did not return to comments. But Mr. Smith, who replaced Mr. Chiklis, said that Collins rarely weighed into the company’s business.
Mr. Collins had an estimated net worth of $ 43.5 million in 2017, according to Roll Call. When the company’s stocks dropped last year, federal prosecutors said that Collins did not sell own shares because he knew he was under investigation. He probably lost millions. According to his 201
7 form, filed in April, Collins owned between $ 1 and $ 5 million in Innate Immunotherapeutics Warehouse.
In June of this year, financial information shows that he sells between $ 15,000 and $ 50,000 in inventory in Innate, his only reported sale of the stock because it lost most of its value.
Also, some of the other Republican congresses or their spouses who invested in Innate made it in January 2017, the same month as Mr Prices Investments came under public scrutiny. Representative John Culberson in Texas bought $ 13,982 in shares and lost $ 9,194 when he sold it in June last year two weeks before the company announced that the drug trial failed.
Mr. Mullin of Oklahoma made the biggest investment; between $ 100,001 and $ 250,000, according to his financial form. He did not list a sale, nor did he do Mr. Long of Missouri, which invested between $ 15,001 and $ 50,000, according to his report. Colorado representative Doug Lamborn, whose wife had purchased between $ 15,001 and $ 50,000, reported a sale on June 27, less than $ 1000, indicating that the couple lost most of the investment.
Representative K. Michael Conaway of Texas reported making two investments between $ 1000 and $ 15,000 in Innate, approximately the same time last year.